WREG1mon
Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease
INDIANAPOLIS, Aug. 16, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Morphic Holding, Inc. (NASDAQ: MORF). Morphic is a ...
Investing26d
Morphic Holding (MORF) Earnings Dates & Reports
View upcoming earnings forecasts and in-depth analysis of company forecasts.
Investing1mon
Eli Lilly completes Morphic acquisition to bolster immunology offerings
INDIANAPOLIS - Eli Lilly and Company (NYSE: NYSE:LLY) has finalized its purchase of biopharmaceutical firm Morphic Holding, Inc. (NASDAQ: NASDAQ:MORF), a move aimed at enhancing its portfolio of ...
Stockhouse1mon
Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease
INDIANAPOLIS, Aug. 16, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Morphic Holding, Inc. (NASDAQ: MORF). Morphic is a ...
Investing1mon
Eli Lilly completes Morphic acquisition to bolster immunology offerings
INDIANAPOLIS - Eli Lilly and Company (NYSE: NYSE:LLY) has finalized its purchase of biopharmaceutical firm Morphic Holding, Inc. (NASDAQ: NASDAQ:MORF), a move aimed at enhancing its portfolio of ...
The Victoria Advocate1mon
Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease
Broadens Lilly's immunology pipeline with Morphic's oral integrin therapies, including MORF-057 ...
Yahoo Finance1mon
Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease
today announced the successful completion of its acquisition of Morphic Holding, Inc. (NASDAQ: MORF). Morphic is a biopharmaceutical company developing oral integrin therapies for treatment of serious ...